Global Pain Management Devices And Therapies Market 2024 , Forecast To 2033
7 Mar, 2024
The pain management devices and therapies market (5) has witnessed rapid growth, projected to increase from $4.38 billion in 2023 to $4.83 billion in 2024 at a CAGR of 10.3%. This growth is fueled by factors such as increasing prevalence of chronic pain and demand for personalized pain management. Looking ahead, the market is expected to continue its rapid growth, reaching $6.49 billion in 2028 at a CAGR of 7.6%, driven by non-opioid alternatives, digital health, and rising opioid epidemic concerns, with trends including advances in pain management technology and neuromodulation devices shaping its evolution.
Global Pain Management Devices And Therapies Market Key Driver
The demand for pain management devices is increasing due to the rise in chronic diseases (5). With approximately 45% of Americans suffering from at least one chronic disease, there is a growing need for pain management drugs and therapies, driving market growth in pain management devices and therapies.
Get A Free Sample Of The Global Pain Management Devices And Therapies Market ReportGlobal Pain Management Devices And Therapies Market Segments
The pain management devices and therapies market covered in this report is segmented –
1) By Type: Electrical Stimulators, Ablation Devices, Neurostimulators, Analgesic Pumps
2) By Neurostimulation Devices: Spinal Cord Stimulation (SCS) Devices, Deep Brain Stimulation Devices, Vagus Nerve Stimulation Devices, Sacral Nerve Stimulation Devices
3) By Electrical Stimulation Devices: Transcutaneous Electrical Nerve Stimulation (TENS) Devices, Neuromuscular Electrical Stimulation (NMES/EMS) Devices, Combination Devices, Electrotherapy Devices, TNS
4) By Ablation Devices: Radiofrequency Ablation Devices, Cryoablation Devices
5) By Analgesic Infusion Pumps: Intrathecal Infusion Pumps, External Infusion Pumps
6) By Application: Neuropathic Pain, Cancer Pain, Facial & Migraine Pain, Musculoskeletal Pain, Trauma
By Geography: The countries covered in the pain management devices and therapies market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.
North America was the largest region in the pain management devices and therapies market in 2023. Western Europe was the second-largest region in the pain management devices and therapies market report. The regions covered in the pain management devices and therapies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
Major Pain Management Devices And Therapies Industry Players
Abbott Laboratories; AstraZeneca plc; Pfizer Inc.; Boston Scientific Corporation; GlaxoSmithKline plc; Teva Pharmaceutical Industries Ltd.; Medtronic plc; Novartis AG; Baxter International Inc.; Johnson & Johnson; Eli Lilly & Company; Endo Health Solutions Inc.; Smiths Medical Inc.; Becton Dickinson and Company; AbbVie Inc.; Astellas Pharma Inc.; Bayer AG; DJO Global Inc.; Halyard Health Inc.; B. Braun Melsungen AG; Neurotech Na; Nevro Corp; Sanofi SA; Purdue Pharma LP; Zogenix Inc.; Bausch Health Companies Inc.; NeuroMetrix Inc.; Medovex Corporation; Halyard Health Inc.; Flowonix Medical Inc.; Pain Management Technologies Inc.
Get The Full Global Pain Management Devices And Therapies Market Report
Pain Management Devices And Therapies Market Overview
The pain management devices and therapies manage chronic and critical pain in patients suffering from various conditions, such as cancer and neurological disorder. These are mainly used for spinal cord stimulation, sacral nerve stimulators, and deep brain stimulation.